BSECompany Update1d ago · 4 Sept 2026, 12:35 pm
We are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.
Senores Pharmaceuticals Ltd · 544319
✦ AI SummaryResults
Senores Pharmaceuticals Ltd has published a newspaper advertisement for its 9th Annual General Meeting, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
3cc82321-8604-4eae-88e6-1fb78c17470f.pdf
View document text
Date: September 04, 2026
To, To,
Sr. General Manager Sr. General Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
BSE Scrip Code: 544319 NSE Symbol: SENORES
Sub.: Newspaper Advertisement – Nineth (9th) Annual General Meeting of the Members of the
Company
Dear Sir/Madam,
Pursuant to Regulation 30 aof the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the Newspaper
Advertisement published, in Financial Express –English (All India Edition) and Gujarati Edition, in
connection with the Nineth (9th ) Annual General Meeting of the of the Company.
This intimation is also being uploaded on the website of the Company i.e. www.senorespharma.com.
You are requested to take the same on record.
Thanking you.
For Senores Pharmaceuticals Limited
Shilpa Sharma
Company Secretary and Compliance Officer
ICSI Membership No.: A34516
Enclosures: As above
Senores Pharmaceuticals Limited
1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,
Ambali Bopal Road, Ahmedabad-380054, Gujarat, India
P: +91 79 2999 9857 | E: info@senorespharma.com
W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263
CIN:L51909GJ1992PLC017742
Aû¼ÌAÿ¼ : cs@vinnyoverseas.in ¡¼Ìù¼¬¼¼Ch: www.vinnyoverseas.in
www.bseindia.com@¼‡¼Ì www.nseindia.com@¼‡¼Ì ‡¼Ì£¼‡¼ÿ¼ ½¬¼Lü¼¼Ì(cid:149)ÂhÂd ½mм¼ÌdÂh(cid:149)Â
7000 @¼‡¼Ì 022- 2499 7000 Eм(cid:149) K¼Ìÿ¼ K(cid:149)¡¼¼Ì @¼x¼¡¼¼ evoting@nsdl.co.in ‡¼Ì @¼(cid:149)_
t¼¼(cid:149)ÂQ¼: 04 ¬¼ŠhÌûù¼(cid:149), 2026 ½°(cid:149)¼ÿ¼¼ÿ¼ ]S¼½y£¼[¼Z„ м¼(cid:149)ÌQ¼
CIN: U24290GJ2017PLC100263
¡¼Ìù¼¬¼¼Ch :www.senorespharma.comÙ
Cû¼ÌCÿ¼ :cs@senorespharma.com ö¼Ì‡¼ : +91-79-29999857
https://instavote.linkintime.co.in Eм(cid:149) мr¼ Eмÿ¼ù†¼ (cid:149)°Ì£¼Ì.
enotices@in.mpms.mufg.com‡¼Ì Cû¼ÌCÿ¼ ÿ¼Q¼Â‡¼Ì @¼x¼¡¼¼ hÌÿ¼Â: 022-4918 6000 Eм(cid:149) K¼Ìÿ¼
t¼¼(cid:149)ÂQ¼ : 04.09.2026 û¼Ì‡¼Ì½]ZS¼ m¼ü¼(cid:149)ÌLh(cid:149)